On Point: Biologics Drive Growth in Pre-Filled Syringes.

The article focuses on the result of the rising use and development of biological drugs, the biopharma industry is witnessing an increase in the adoption of prefilled syringes. Topics inlcude the drugs has intended for injection into the eye for the treatment of macular degeneration has related to aging and diabetes, the growth seen in the syringes market to expanding ophthalmic market, and the views of Gregory Sacha, senior research scientist at Baxter BioPharma Solutions, on the same.